• Cinoxacin: Mechanism, Spectrum, and UTI Evidence

  2026-08-09

  The reference study positioned Cinoxacin as a clinically useful quinolone antibiotic by integrating its bacterial DNA synthesis mechanism, activity against urinary gram-negative pathogens, pharmacokinetics, tolerability, and therapeutic evidence. Its main practical contribution was linking rapid urinary exposure and Enterobacteriaceae activity to treatment and prophylaxis strategies for bacterial urinary tract infections.

• Streptavidin – Cy5 for Reliable Cell Assays

  2026-08-08

  Learn how Streptavidin – Cy5 (SKU K1080) can strengthen biotin-based fluorescence workflows used alongside cell viability, proliferation, apoptosis, and cytotoxicity assays. This scenario-driven guide connects spectral selection, storage, controls, interpretation, and vendor evaluation to practical laboratory decisions.

• Propidium Iodide for Toxoplasma Cell Death Assays

  2026-08-07

  Learn how Propidium iodide turns membrane damage into a measurable endpoint for Toxoplasma gondii infection, GRA12 perturbation, viability testing, and cell-cycle profiling. The workflow combines practical PI staining with Annexin V, imaging, and genetic controls to distinguish parasite-associated host-cell injury from assay artifacts.

• Screening MMV Pandemic Box: New Leads Against MDR Pathogens

  2026-08-07

  This study systematically screened 247 compounds from the MMV Pandemic Response Box to identify agents effective against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and clinically relevant fungi. The findings highlight promising candidates for further development and inform future antimicrobial and biofilm inhibition research.

• TCF25 Controls Lysosomal Acidification in Glucose Starvation

  2026-08-06

  Ren et al. (2025) reveal TCF25 as a nutrient sensor that orchestrates metabolic adaptation and cell death during glucose deprivation by enhancing lysosomal acidification via V-ATPase. These findings clarify how cells shift from survival-promoting autophagy to lysosome-dependent cell death under metabolic stress, highlighting TCF25 as a potential therapeutic target for metabolic and ischemic diseases.

• HAUS1 as a Prognostic Biomarker and Immune Modulator in HCC

  2026-08-06

  The referenced study reveals that HAUS1 is highly expressed in hepatocellular carcinoma (HCC) and is linked to poor prognosis, tumor progression, and immune microenvironment alterations. These findings highlight HAUS1's potential as a diagnostic, prognostic, and therapeutic target, underscoring new avenues for biomarker-driven cancer research and therapy.

• Birinapant (TL32711): Advancing Apoptosis Induction in Cance

  2026-08-05

  Birinapant (TL32711) delivers reproducible, high-sensitivity apoptosis induction by targeting IAPs, enabling advanced cancer cell modeling and translational workflows. Recent biomarker discoveries, notably around MDM1 and p53, further empower researchers to overcome therapy resistance using this potent SMAC mimetic from APExBIO.

• Cefodizime: Precision Use of a Third-Gen Cephalosporin in Re

  2026-08-05

  Explore Cefodizime’s molecular pharmacology, immunomodulatory effects, and best practices for precise assay design. This in-depth analysis delivers actionable insights for leveraging this third-generation cephalosporin antibiotic in advanced microbiology research.

• Azathramycin A: Macrolide Antibiotic Innovation in TB Models

  2026-08-04

  Azathramycin A streamlines tuberculosis research by combining potent ribosomal inhibition with workflow flexibility, enabling precise modeling of Mycobacterium tuberculosis infection and resistance mechanisms. This guide translates biophysical insights and real-world protocols into actionable steps for advanced antibiotic discovery.

• Heparin Sodium: Applied Protocols for Thrombosis and Coagula

  2026-08-04

  Heparin sodium from APExBIO empowers precise modeling of blood coagulation and thrombosis, offering high solubility and robust anti-factor Xa activity in both classic and next-generation delivery workflows. This guide translates the latest mechanistic insights and experimental innovations—like exosome-inspired nanoparticle strategies—into practical steps and troubleshooting for researchers.

• Practical Guidance for Cell Counting Kit-8 (CCK-8) Plus Assa

  2026-08-03

  Cell Counting Kit-8 (CCK-8) Plus enables sensitive, rapid assessment of cell viability and cytotoxicity, addressing common workflow bottlenecks in proliferation and drug screening experiments. It is suited for high-throughput and quantitative applications in diverse cell types, but is not designed for endpoint measurements in non-viable or metabolically inactive samples.

• CTOP: Optimizing μ-Opioid Receptor Antagonism in Pain Resear

  2026-08-03

  CTOP stands out as a selective μ-opioid receptor antagonist, empowering researchers to dissect central opioid signaling and mechanical hypersensitivity with unmatched specificity. This article details practical protocols, advanced use cases, and troubleshooting tips based on recent mechanistic breakthroughs—streamlining neuropharmacology and pain mechanism research.

• Levofloxacin: Applied Workflows for DNA Replication and Cell

  2026-08-02

  Levofloxacin, a synthetic fluoroquinolone antibiotic, delivers unmatched precision for bacterial DNA replication studies and bone/cartilage cell assays. Discover stepwise protocols, evidence-backed troubleshooting, and strategic integration for multidomain research advancement.

• Sodium Dicloxacillin Monohydrate: Precision Workflows for MS

  2026-08-01

  Sodium dicloxacillin monohydrate enables reproducible, high-sensitivity workflows for dissecting methicillin-sensitive Staphylococcus aureus (MSSA) pathogenesis in both in vitro and in vivo models. This article details protocol enhancements, troubleshooting tips, and novel assay strategies that uniquely leverage APExBIO’s high-purity β-lactam antibiotic for Gram-positive bacterial infection research.

• Antibacterial Use and Resistance in Psychiatric Hospitals Du

  2026-07-31

  This study provides a detailed, data-driven analysis of antibacterial drug use and bacterial resistance patterns in a psychiatric hospital during the COVID-19 epidemic. By comparing local, provincial, and national antibiotic use and resistance data, the research clarifies unique stewardship challenges and highlights the need for enhanced monitoring to optimize patient outcomes.

16424 records 1/1095 page Next 12345 下5页 Last page